TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.
Merli P, Pagliara D, Galaverna F, Li Pira G, Andreani M, Leone G, Amodio D, Pinto RM, Bertaina A, Bertaina V, Mastronuzzi A, Strocchio L, Boccieri E, Pende D, Falco M, Di Nardo M, Del Bufalo F, Algeri M, Locatelli F.
Merli P, et al. Among authors: del bufalo f.
Blood Adv. 2022 Jan 11;6(1):281-292. doi: 10.1182/bloodadvances.2021005628.
Blood Adv. 2022.
PMID: 34592755
Free PMC article.